meta_pixel
Tapesearch Logo
Log in
Bloomberg Surveillance

Surveillance: Eli Lilly CEO Says Science Will Win

Bloomberg Surveillance

Bloomberg

News, Business, Business News, Investing

3.81.2K Ratings

🗓️ 27 October 2020

⏱️ 32 minutes

🧾️ Download transcript

Summary

Dave Ricks, Eli Lilly Chairman & CEO, says science will win in the fight against Covid-19. Andrew Slimmon, Morgan Stanley Investment Management Senior Portfolio Manager, warns investors to resist the urge to overreact as the U.S. election nears. Chris Watling, Longview Economics CEO, examines the trade-offs of helicopter money. Tina Fordham, Avonhurst Advisory Services Head of Global Political Strategy, discusses how Biden and Trump differ on foreign policy.

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0

With Bloomberg you get the story behind the story, the story behind the global birth rate,

0:04.7

behind your EV batteries environmental impact, behind sand. Yeah, sand, you get context.

0:10.8

And context changes everything. Go to Bloomberg.com to get context. Welcome to the Bloomberg surveillance podcast. I'm Tom Keene.

0:28.0

Daily, we bring you insight from the best in economics finance investment and international relations find

0:35.4

Bloomberg surveillance on Apple Podcasts soundcloud bloomer.com and of course on the

0:41.4

Bloomberg right now and this is a joy as we consider this terrible pandemic and all of us at Bloomberg,

0:47.0

surveillance have done everything we can to bring you experts.

0:51.0

David Ricks is out of Purdue, he runs a shop called Eli Lilly and his Indiana, and they are dominant in our history of finding solutions, whether it's insulin,

1:01.0

arithmetic, and particularly what Lily did on polio vaccine in 1955

1:08.4

was absolutely original, absolutely historic. The phrase from that time is safe, effective, and potent.

1:17.0

That is the great hope right now for all of us.

1:20.0

Dave Ricks, how close are we to safe, effective, and potent?

1:25.0

Well, thanks for having me on.

1:27.0

It's obviously a time when the importance of our scientists' work is at a high, as you mentioned back to our days with the polio

1:35.0

vaccine that's really in our blood here at Lilius to respond to these public

1:37.8

health crises. We're working on the medicine side and I think we are close to understanding that treatment

1:45.6

with monoclonal antibodies which we're making and others are early in the

1:50.5

disease can make a significant difference.

1:52.9

We announced data earlier in October regarding that,

1:55.3

and we've got an application at the FDA

1:58.5

reviewing that very data.

2:00.2

Which therapy has the best outcome where we can say we have a vaccine?

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.